secwatch / observer
8-K filed February 1, 2023, 6:59 PM ET ticker LFCR CIK 0001005286
other material confidence medium sentiment negative materiality 0.75

LIFECORE BIOMEDICAL, INC. DE (LFCR): auditor change — Lifecore restates FY2022 and Q1 FY2023 financials due to impairment errors in Curation Foods

LIFECORE BIOMEDICAL, INC. DE

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE reported that prior financial statements should not be relied upon.

Action
non reliance
Exact text from the filing
d financial statements as of and for the year ended May 29, 2022 and (ii) unaudited consolidated financial statements as of and for the three months ended August 28, 2022 (collectively, the “Prior Financial Statements”) should no longer be relied upon. This determination resulted from the identification of errors in the Prior Financial Statements identified by the Company related to certain non-cash impairment charges related to the Company’s Curation Foods business contained in the Prior Financial Statements. The Company has assessed the materiality of these errors in accordance with the U.S. Securities and Exchange Commission Staff Accounting Bulletin No. 99 (“SAB”), Materiality and SAB No. 108, Quantifying Financial Statement Misstatements, and has concluded that the Prior Financial Statements should be restated. The restatement is not currently expected by the Company to have an adve
View on SEC.gov

12 auditor changes filed in the last 30 days. Browse all auditor changes →

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR
accession 0001005286-23-000032
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.